(Press-News.org) MILAN — A new study reveals hormonal and biochemical factors that affect alcohol dependence (also known as Alcohol Use Disorder), suggesting that men and women with alcohol problems may benefit from different treatments.
Scientists have known that men and women have different risks related to alcohol misuse and related problems and that alcohol treatments may need to be tailored differently to men and women. However, the biological mechanisms underlying those differences are not well understood.
"This is the first large study to confirm that some of the variability in Alcohol Use Disorder (AUD) and related problems is associated with particular combinations of hormones and chemical biomarkers in men and in women. It may mean that sex-specific treatments can be tailored to improve responses for men and women with alcohol problems" said lead researcher Victor Karpyak, Professor of Psychiatry at Mayo Clinic in Rochester, Minnesota (USA). This work is presented at the ECNP Congress in Milan, Italy.
As part of a research project researching the alcohol dependence medication acamprosate, the researchers looked at hormonal and protein markers of 268 men and 132 women with Alcohol Use Disorder. They correlated these markers with psychological markers, such as depressed mood, anxiety, craving, alcohol consumption and treatment outcomes during the first 3 months of treatment.
At the beginning of the trial – before anyone had taken any medication – the researchers tested men and women for several sex-specific blood markers, including sex hormones (testosterone, estrogens, progesterone) as well as proteins known to impact their reproduction (such as follicle stimulating hormone, and luteinizing hormone) or bioavailability of these hormones in the blood (albumin and sex hormone-binding globulin).
They found that at the beginning of the trial men with Alcohol Use Disorder, symptoms of depression, and higher craving for alcohol, also had lower levels of the hormones testosterone, estrone, estradiol, as well as the protein sex hormone binding globulin. No such associations were found in women with AUD.
Professor Karpyak said, “We found that there were different associations in men and women. For example, women who had higher levels of testosterone, sex hormone binding globulin, and albumin were also more likely to relapse during the first three months of treatment compared to women with lower levels of those biochemical markers. No such relationships were found in men.
“These hormones and proteins are known to have an influence on behaviour, and indeed we see an association between different levels of these compounds and different behavioural aspects of alcohol use disorder, although we can’t for sure say that one directly causes another. What it does mean is that if you are treating a man and a woman for alcoholism, you are dealing with different biochemical and psychological starting points. This implies that what works for a man may not work for a woman, and vice versa.
“This is the first study large enough to be able to confirm that particular combinations of sex hormones and related proteins may be part of the biological differences in how alcoholism manifests itself in men and women. We need more research to understand what this means for disease progression and its treatment. Given that many of those differences are related to sex hormones, we particularly want to see how the dramatic hormonal change women experience during menstrual cycle and at menopause may affect the biochemistry of alcoholism, and guide treatment efforts”.
Commenting, Dr Erika Comasco, Associate Professor in Molecular Psychiatry, Uppsala University, Sweden, said,” This research is an important step forward to gender equity in medicine. The findings provide an important first insight into the relationship between sex hormones and alcohol use disorder treatment. While sex differences in the way the disorder manifests itself are known, these results suggest that sex hormones may modulate treatment response, potentially supporting sex-specific pharmacological intervention. However, hormone fluctuations related to the menstrual cycle are also potential modulators of alcohol misuse, warranting further investigation into their role in treatment and relapse outcomes for female patients.”
This is an independent comment, Professor Comasco was not involved in this work.
Notes
Sex Hormone Binding Globulin (SHBG) and Albumin are proteins made by the liver. SHBG carries the hormones estrogen, dihydrotestosterone (DHT), and testosterone in the bloodstream, whereas albumin helps control fluid in the blood, as well as carrying hormones and some chemicals in the bloodstream (simplified definitions).
END
Study shows alcohol-dependent men and women have different biochemistries, so may need different treatments
2024-09-22
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Researchers find that Antidepressants may improve brain function
2024-09-22
Researchers have found that SSRI (Selective Serotonin Reuptake Inhibitors) antidepressants have the potential to improve certain cognitive functions, such as verbal memory. They measured brain function in patients before and after taking the SSRI escitalopram and correlated this to a drop in the level of one of the serotonin receptors in the brain and to cognitive improvements during treatment. This work is presented for the first time at the ECNP Conference in Milan, after recent publication in the journal Biological Psychiatry.
Serotonin is often described as a ‘feel good’ chemical, and higher levels of serotonin circulating in the brain contribute to a sense of well-being, ...
Aviation can achieve Net-Zero by 2050 if immediate action is taken, says University of Cambridge report
2024-09-22
Cambridge University has today released a groundbreaking report outlining a five-year roadmap to help the aviation sector achieve net-zero climate impact by 2050.
Despite ambitious pledges from governments and industry, the aviation sector remains significantly off course in its efforts to achieve net-zero emissions by 2050. The report, titled “Five Years to Chart a New Future for Aviation,” outlines four 2030 Sustainable Aviation Goals—specific, actionable steps that must be initiated immediately and completed within five years if the aviation sector is to be on track to achieve net-zero by 2050.
The 2030 Goals outlined in the report are:
Accelerating the deployment ...
Study shows psychedelic drug psilocybin gives comparable long-term antidepressant effects to standard antidepressants, but may offer additional benefits
2024-09-22
A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional longer-term benefits.
The comparison, between psilocybin (the active ingredient in “magic mushrooms”) and the SSRI escitalopram gave similar long-term improvements in depressive symptoms over a 6-month period, however patients taking psilocybin also reported better psychosocial functioning including experiencing a greater sense of meaning ...
Study finds symptoms of depression during pregnancy linked to specific brain activity: scientists hope to develop test for “baby blues” risk
2024-09-21
Milan, Italy: Around 80% of women suffer from “baby blues” after the birth of their child. Normally this is a brief period of feeling down which disappears in a few days. But around 1 woman in 7 develops postpartum depression; this is a more serious depression which can affect how mothers bond with their baby and can have long-term consequences. These women seem unable to regulate the negative emotions which can follow giving birth.
Now a group of European Reesearchers have found that in healthy pregnant women activity in a specific area deep in the brain is linked to regulation of negative ...
Sexual health symptoms may correlate with poor adherence to adjuvant endocrine therapy in Black women with breast cancer
2024-09-21
LOS ANGELES – Among patients with early-stage breast cancer treated with adjuvant endocrine therapy (AET), symptoms related to sexual health were associated with decreased adherence to treatment in Black women, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.
Patients with hormone receptor-positive breast cancer are commonly given endocrine therapy—treatments that block estrogen signaling in the breast—after receiving surgery, radiation, or chemotherapy. The recommended regimen for AET ...
Black patients with triple-negative breast cancer may be less likely to receive immunotherapy than white patients
2024-09-21
LOS ANGELES – In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates than white patients, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.
Black women are disproportionately affected by TNBC, an aggressive subtype of breast cancer defined by the lack of three cell surface receptors. The absence of these receptors means that patients with TNBC are ineligible for many of the molecularly targeted therapies used to treat other breast cancer subtypes, explained ...
Affordable care act may increase access to colon cancer care for underserved groups
2024-09-21
LOS ANGELES – The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white patients, patients from rural areas, and patients from the most deprived neighborhoods in Pennsylvania, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.
“The ACA was the largest change to the health insurance system in the United States since the introduction of Medicare and Medicaid ...
UK study shows there is less stigma against LGBTQ people than you might think, but people with mental health problems continue to experience higher levels of stigma
2024-09-20
A study of stigma against LGBTQ (lesbian, gay, bisexual, transgender and queer) people in British Society has shown that there is less stigma against these groups that might be expected from social and media perceptions. The same study looked at stigma against people with mental health problems and discovered that they continue to experience higher levels of stigma. This work will be presented at the ECNP conference in Milan. This is an advance press release see note below.
Researcher Professor Karen Ersche (University of Cambridge) said, “Our aim was to look at the level of stigma against LGBTQ people in British society, and also to look at stigma ...
Bringing lost proteins back home
2024-09-20
Cells are highly controlled spaces that rely on every protein being in the right place. Many diseases, including cancers and neurodegenerative disorders, are associated with misplaced proteins. In some cancers, for instance, a protein that normally stands watch over DNA replicating in the nucleus is sent far from the DNA it is meant to monitor, allowing cancers to grow.
Steven Banik, assistant professor of chemistry in the School of Humanities and Sciences and institute scholar at Sarafan ChEM-H at Stanford University, and his lab have developed a new method to help force misplaced proteins back to their proper homes within cells. The method ...
Better than blood tests? Nanoparticle potential found for assessing kidneys
2024-09-20
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney disease than standard laboratory blood tests. Based on their study in mice, they also found that caution may be warranted in employing renal-clearable nanomedicines to patients with compromised kidneys.
Before administering renal-clearable drugs, doctors routinely check a patient’s kidney function by testing their ...